Author information

Inquiry content

Dear R&D and Purchase team,

Greetings !

I am Vani Mattha, Sr. Manager - CDMO - Business Development at Chieron. I am writing to introduce our organization as an India-based CDMO specializing in providing the custom and complex synthesis solutions for the KSMs, Intermediates and advanced intermediates in the drug-substance development space. We support global innovators and CDMO players with the process development, scale-up, and commercial manufacturing, backed by strong regulatory and quality systems.

We understand that Dongbang is actively involved in new API development with different therapeutic categories by holding international partnerships, and we believe there could be meaningful opportunities for collaboration where Chieron can possible contribute for Initial raw materials or the intermediates development. 

We Operate 3 R&D centers and multiple manufacturing units with an overall reactor capacity exceeding 420KL. Our sites are PSCI compliant and recognized by Ecovadis gold and silver. We hold the required regulatory accreditations to our factories to support global markets like WHO GMP, KFDA, PMDA, USFDA etc.

I believe, a short introductory meeting will greatly help us to show case our chemistry and manufacturing capabilities and jointly we can discuss for collaborative opportunities where Dangbang can take leverage of our R&D and manufacturing capabilities.

I am attaching our corporate presentation here for ready reference, I look forward to hear back from you.